Corrigendum to "PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease" [Metabolism Volume 150, January 2024, 155736, PMID: 7967646]

Vatsal Sachan¹, Maïlys LeDévéhat¹, Anna Roubtsova¹, Rachid Essalmani¹, Jean-Francois Laurendeau², Damien Garçon¹, Delia Susan-Sesiga¹, Stéphanie Duval¹, Sahar Mikaeeli¹, Josée Hamelin¹, Alexandra Evagelidis¹, Michael Chong³, Guillaume Paré³, Elizabeta Chernetsova⁴, Zu-Hua Gao⁴, Isabelle Robillard⁵, Matthieu Ruiz⁵, Vincent Quoc-Huy Trinh⁶, Jennifer L Estall⁷, May Faraj⁸, Richard C Austin⁹, Martin Sauvageau², Annik Prat¹, Robert S Kiss¹⁰, Nabil G Seidah¹¹

Affiliations

¹ Biochemical Neuroendocrinology, Institut de Recherches Cliniques de Montréal (IRCM), affiliated to the Université de Montréal, Montréal, QC, Canada.
² RNA and Noncoding Mechanisms of Disease, Institut de Recherches Cliniques de Montréal (IRCM), affiliated to the Université de Montréal, Montréal, QC, Canada.
³ Department of Biochemistry & Biomedical Sciences, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada.
⁴ Department of Pathology, McGill University Health Centre, Montréal, QC, Canada.
⁵ Montreal Heart Institute, Metabolomics Platform, Montreal, Quebec, Canada; Department of Nutrition, Université de Montréal, Montréal, QC, Canada.
⁶ Departement of Pathology and Cellular Biology, Institut de Recherche en Immunologie et Cancérologie, Université de Montréal, Montréal, QC, Canada.
⁷ Molecular Mechanisms of Diabetes, Institut de Recherches Cliniques de Montréal (IRCM), affiliated to the Université de Montréal, Montréal, QC, Canada.
⁸ Nutrition Department, Université de Montréal, Research Unit on Nutrition, Lipoproteins and Cardiometabolic Diseases, Institut de Recherches Cliniques de Montréal (IRCM), Montréal, QC, Canada.
⁹ Department of Medicine, Division of Nephrology, McMaster University, The Research Institute of St. Joe's Hamilton and the Hamilton Center for Kidney Research, Hamilton, ON, Canada.
¹⁰ McGill University Health Centre Research Institute, Montréal, QC, Canada.
¹¹ Biochemical Neuroendocrinology, Institut de Recherches Cliniques de Montréal (IRCM), affiliated to the Université de Montréal, Montréal, QC, Canada. Electronic address: seidahn@ircm.qc.ca.

PMID: 39298889
DOI: 10.1016/j.metabol.2024.156032

Published Erratum

Corrigendum to "PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease" [Metabolism Volume 150, January 2024, 155736, PMID: 7967646]

Vatsal Sachan et al. Metabolism. 2024 Dec.

. 2024 Dec:161:156032.

doi: 10.1016/j.metabol.2024.156032. Epub 2024 Sep 19.

Authors

Affiliations

¹ Biochemical Neuroendocrinology, Institut de Recherches Cliniques de Montréal (IRCM), affiliated to the Université de Montréal, Montréal, QC, Canada.
² RNA and Noncoding Mechanisms of Disease, Institut de Recherches Cliniques de Montréal (IRCM), affiliated to the Université de Montréal, Montréal, QC, Canada.
³ Department of Biochemistry & Biomedical Sciences, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada.
⁴ Department of Pathology, McGill University Health Centre, Montréal, QC, Canada.
⁵ Montreal Heart Institute, Metabolomics Platform, Montreal, Quebec, Canada; Department of Nutrition, Université de Montréal, Montréal, QC, Canada.
⁶ Departement of Pathology and Cellular Biology, Institut de Recherche en Immunologie et Cancérologie, Université de Montréal, Montréal, QC, Canada.
⁷ Molecular Mechanisms of Diabetes, Institut de Recherches Cliniques de Montréal (IRCM), affiliated to the Université de Montréal, Montréal, QC, Canada.
⁸ Nutrition Department, Université de Montréal, Research Unit on Nutrition, Lipoproteins and Cardiometabolic Diseases, Institut de Recherches Cliniques de Montréal (IRCM), Montréal, QC, Canada.
⁹ Department of Medicine, Division of Nephrology, McMaster University, The Research Institute of St. Joe's Hamilton and the Hamilton Center for Kidney Research, Hamilton, ON, Canada.
¹⁰ McGill University Health Centre Research Institute, Montréal, QC, Canada.
¹¹ Biochemical Neuroendocrinology, Institut de Recherches Cliniques de Montréal (IRCM), affiliated to the Université de Montréal, Montréal, QC, Canada. Electronic address: seidahn@ircm.qc.ca.

PMID: 39298889
DOI: 10.1016/j.metabol.2024.156032

No abstract available

PubMed Disclaimer

Erratum for

PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease.
Sachan V, Le Dévéhat M, Roubtsova A, Essalmani R, Laurendeau JF, Garçon D, Susan-Resiga D, Duval S, Mikaeeli S, Hamelin J, Evagelidis A, Chong M, Paré G, Chernetsova E, Gao ZH, Robillard I, Ruiz M, Trinh VQ, Estall JL, Faraj M, Austin RC, Sauvageau M, Prat A, Kiss RS, Seidah NG. Sachan V, et al. Metabolism. 2024 Jan;150:155736. doi: 10.1016/j.metabol.2023.155736. Epub 2023 Nov 13. Metabolism. 2024. PMID: 37967646

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease" [Metabolism Volume 150, January 2024, 155736, PMID: 7967646]

Affiliations

Corrigendum to "PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease" [Metabolism Volume 150, January 2024, 155736, PMID: 7967646]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources